4.3 Review

Dendritic cells: driving the differentiation programme of T cells in viral infections

期刊

IMMUNOLOGY AND CELL BIOLOGY
卷 86, 期 4, 页码 333-342

出版社

WILEY
DOI: 10.1038/icb.2008.15

关键词

T cells; immunity; memory; virus; antigen presentation

资金

  1. Howard Hughes Medical Institute Funding Source: Medline
  2. Wellcome Trust Funding Source: Medline

向作者/读者索取更多资源

Protective immunity against viral pathogens depends on the generation and maintenance of a small population of memory CD8(+) T cells. Successful memory cell generation begins with early interactions between naive T cell and dendritic cells (DCs) within the inflammatory milieu of the secondary lymphoid tissues. Recent insights into the role of different populations of DCs, and kinetics of antigen presentation, during viral infections have helped to understand how DCs can shape the immune response. Here, we review the recent progress that has been made towards defining how specific DC subsets drive effector CD8(+) T-cell expansion and differentiation into memory cells. Further, we endeavour to examine how the molecular signals imparted by DCs coordinate to generate protective CD8(+) T-cell immunity.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Allergy

Impact of diet and the bacterial microbiome on the mucous barrier and immune disorders

Charlotte A. Alemao, Kurtis F. Budden, Henry M. Gomez, Saima F. Rehman, Jacqueline E. Marshall, Shakti D. Shukla, Chantal Donovan, Samuel C. Forster, Ian A. Yang, Simon Keely, Elizabeth R. Mann, Emad M. El Omar, Gabrielle T. Belz, Philip M. Hansbro

Summary: The prevalence of chronic immune and metabolic disorders is increasing rapidly, with significant associations found between alterations in the microbiome, diet, and mucous barriers in the onset and progression of these diseases. The interplay between diet, microbiome, and mucous barrier has gained attention in understanding major immune/metabolic disorders.

ALLERGY (2021)

Article Cell Biology

Systemic administration of IL-33 induces a population of circulating KLRG1hitype 2 innate lymphoid cells and inhibits type 1 innate immunity against multiple myeloma

Camille Guillerey, Kimberley Stannard, Jason Chen, Sophie Krumeich, Kim Miles, Kyohei Nakamura, Jessica Smith, Yuan Yu, Susanna Ng, Heidi Harjunpaa, Michele W. L. Teng, Christian Engwerda, Gabrielle T. Belz, Mark J. Smyth

Summary: The study found that the growth of multiple myeloma was associated with changes in BM ILC2s, characterized by increased expression of maturation markers and reduced cytokine response. A subset of KLRG1(hi)ILC2s which preferentially accumulated in the liver and spleen was identified.

IMMUNOLOGY AND CELL BIOLOGY (2021)

Article Cell Biology

Differences in pulmonary group 2 innate lymphoid cells are dependent on mouse age, sex and strain

Svenja Loering, Guy J. M. Cameron, Nirmal P. Bhatt, Gabrielle T. Belz, Paul S. Foster, Philip M. Hansbro, Malcolm R. Starkey

Summary: Lung innate lymphoid cells (ILCs) show differences in numbers, cell surface antigen expression, and cytokine levels between neonatal and adult mice. Female mice have more lung ILCs with different antigen expression compared to males. Additionally, mouse strain impacts ILC numbers and expression in the lung.

IMMUNOLOGY AND CELL BIOLOGY (2021)

Article Oncology

Host IL11 Signaling Suppresses CD4+ T cell-Mediated Antitumor Responses to Colon Cancer in Mice

Jennifer Huynh, David Baloyan, David Chisanga, Wei Shi, Megan O'Brien, Shoukat Afshar-Sterle, Mariah Alorro, Lokman Pang, David S. Williams, Adam C. Parslow, Pathum Thilakasiri, Moritz F. Eissmann, Louis Boon, Frederick Masson, Ashwini L. Chand, Matthias Ernst

Summary: IL11 is a member of the IL6 family of cytokines, and plays a role in regulating CD4+ T cell-mediated antitumor responses by suppressing the activity of host CD4(+) T cells in the tumor microenvironment. This suggests a potential immunomodulatory role for IL11 in colon cancer development that could be targeted for anticytokine-based therapy.

CANCER IMMUNOLOGY RESEARCH (2021)

Article Immunology

Blockade of the co-inhibitory molecule PD-1 unleashes ILC2-dependent antitumor immunity in melanoma

Nicolas Jacquelot, Cyril Seillet, Minyu Wang, Angela Pizzolla, Yang Liao, Soroor Hediyeh-zadeh, Sharon Grisaru-Tal, Cynthia Louis, Qiutong Huang, Jaring Schreuder, Fernando Souza-Fonseca-Guimaraes, Carolyn A. de Graaf, Kevin Thia, Sean Macdonald, Mary Camilleri, Kylie Luong, Shengbo Zhang, Michael Chopin, Tristan Molden-Hauer, Stephen L. Nutt, Viktor Umansky, Bogoljub Ciric, Joanna R. Groom, Paul S. Foster, Philip M. Hansbro, Andrew N. J. McKenzie, Daniel H. D. Gray, Andreas Behren, Jonathan Cebon, Eric Vivier, Ian P. Wicks, Joseph A. Trapani, Ariel Munitz, Melissa J. Davis, Wei Shi, Paul J. Neeson, Gabrielle T. Belz

Summary: ILC2s play a critical role in melanoma immunity by producing cytokines that enhance antitumor responses. High infiltration of ILC2s in melanoma is associated with good clinical prognosis, but their antitumor functions may be restricted by programmed cell death protein-1.

NATURE IMMUNOLOGY (2021)

Article Clinical Neurology

Influenza vaccination induces autoimmunity against orexinergic neurons in a mouse model for narcolepsy

Raphael Bernard-Valnet, David Frieser, Xuan-Hung Nguyen, Leila Khajavi, Clemence Queriault, Sebastien Arthaud, Silvia Melzi, Maxime Fusade-Boyer, Frederick Masson, Matthias Zytnicki, Abdelhadi Saoudi, Yves Dauvilliers, Christelle Peyron, Jan Bauer, Roland S. Liblau

Summary: This study reveals that Pandemrix (R) vaccination may induce narcolepsy through immune cross-reactivity with a self-antigen, leading to an immunopathological process. This process relies on the synergy between CD4 and CD8 T cells.
Review Immunology

Innate lymphoid cells and cancer

Nicolas Jacquelot, Cyril Seillet, Eric Vivier, Gabrielle T. Belz

Summary: Innate lymphoid cells (ILCs) play a role in immune responses and have been found to have pleiotropic effects in various tissues, including both tissue repair and immunopathology toward allergens and promotion of tumorigenesis. Recent studies suggest that non-NK ILCs might be harnessed for anti-tumor responses. Gabrielle Belz and colleagues review the influence of ILCs on cancer immune responses.

NATURE IMMUNOLOGY (2022)

Article Cell Biology

Tissue-resident CD8+ T cells drive compartmentalized and chronic autoimmune damage against CNS neurons

David Frieser, Aurora Pignata, Leila Khajavi, Danielle Shlesinger, Carmen Gonzalez-Fierro, Xuan-Hung Nguyen, Alexander Yermanos, Doron Merkler, Romana Hoftberger, Virginie Desestret, Katharina M. Mair, Jan Bauer, Frederick Masson, Roland S. Liblau

Summary: This study reveals the important role of tissue-resident memory T cells, particularly pathogenic CD8(+) T cells, in chronic autoimmune diseases of the central nervous system. These cells are crucial for sustaining chronic inflammation and progressive loss of neurons, and they exhibit phenotypic and functional heterogeneity. The presence and functional output of tissue-resident CD8(+) T cells depend critically on CD4(+) T cells. Therefore, therapies targeting this compartmentalized autoreactive T cell subset may be effective for treating CNS autoimmune diseases.

SCIENCE TRANSLATIONAL MEDICINE (2022)

Review Immunology

Tissue-resident CD8 T cells in central nervous system inflammatory diseases: present at the crime scene and...guilty

Doron Merkler, Ilena Vincenti, Frederick Masson, Roland S. Liblau

Summary: Tissue-resident memory T cells (T-RM) are a subset of T cells that are retained in tissues and play important roles in protection against reinfection and antitumor responses. The increased density of CD8 T-RM in the central nervous system (CNS) of patients with neuroinflammatory diseases suggests its potential contribution to the pathogenesis of these diseases.

CURRENT OPINION IN IMMUNOLOGY (2022)

Editorial Material Immunology

ZBTB46 in ILC3: shared transcriptional infrastructure defines gut-protective capabilities

Sophie Curio, Gabrielle T. Belz

Summary: In a new study, researchers discovered that the expression of transcription factor ZBTB46 in ILC3s in the mouse colon plays a crucial role in regulating inflammatory responses.

TRENDS IN IMMUNOLOGY (2022)

Review Immunology

Metabolic features of innate lymphoid cells

Huiyang Yu, Nicolas Jacquelot, Gabrielle T. Belz

Summary: This article reviews the critical role of innate lymphoid cells in tissue protection and immunity in animals, and discusses their metabolic pathways and adaptability to changing conditions. Reprogramming immune cell metabolism may offer new strategies for modulating immune cell behavior and treating various diseases.

JOURNAL OF EXPERIMENTAL MEDICINE (2022)

Editorial Material Immunology

Gutsy sensations modulate intestinal disease

Wang Cao, Gabrielle Belz

Summary: Pain is a characteristic symptom of intestinal inflammation. Two articles published in Cell by Zhang et al. and by Yang et al. reveal how gut sensory neurons identify bacterial pathogens, modulate gut microbiome composition, and activate immune regulatory mechanisms.

TRENDS IN IMMUNOLOGY (2023)

Article Cell Biology

Survival and division fate programs are preserved but retuned during the naive to memory CD8+ T-cell transition

Susanne Heinzel, Hochan Cheon, Gabrielle T. Belz, Philip D. Hodgkin

Summary: Memory T cells and naive T cells have similarities in maintenance and response dynamics, but may differ in cellular fate programs. Resting memory T cells show heightened sensitivity to homeostatic cytokines and undergo controlled proliferation and return to quiescence similar to naive T cells. However, memory T cells may have reduced expansion capacity in response to activating signals compared to naive T cells.

IMMUNOLOGY AND CELL BIOLOGY (2023)

Review Oncology

Innate lymphoid cells: potential targets for cancer therapeutics

Chun Ki Ng, Gabrielle T. Belz

Summary: Innate lymphoid cells (ILCs) are a group of immune cells that can respond rapidly to changing microenvironmental cues. They can either protect against tumor development or promote tumor progression and resistance to immunotherapy. This review discusses the regulation of ILCs and the potential for using their functional plasticity to develop therapeutic strategies to enhance immune responses and improve patient outcomes.

TRENDS IN CANCER (2023)

Article Oncology

Tertiary lymphoid structures and B lymphocytes in cancer prognosis and response to immunotherapies

N. Jacquelot, J. Tellier, S. L. Nutt, G. T. Belz

Summary: Tertiary lymphoid structures (TLS) are ectopic cellular aggregates resembling secondary lymphoid organs. Found in solid tumors, TLS exhibit varying degrees of maturation and are composed of diverse immune cell types that actively drive the immune response against tumor development and progression. Their role, prognostic value, and potential for immunotherapeutic targeting are discussed in this review.

ONCOIMMUNOLOGY (2021)

暂无数据